Ligand validation:6E7S

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6E7S_NAG_A_501	37%	75%	0.236	0.933	0.29	0.67	-	-	0	0	100%	1
6E7S_NAG_C_501	27%	76%	0.243	0.916	0.37	0.56	-	-	4	0	87%	1
6E7S_NAG_B_502	12%	75%	0.268	0.798	0.3	0.67	-	-	0	0	100%	1
6E7S_NAG_B_501	8%	76%	0.274	0.745	0.26	0.69	-	-	0	0	100%	1
6E7S_NAG_D_502	3%	77%	0.401	0.728	0.29	0.62	-	-	0	0	100%	1
6E7S_NAG_D_501	1%	25%	0.339	0.567	0.63	2.38	-	3	2	0	100%	1
6E7S_NAG_C_504	1%	78%	0.412	0.639	0.29	0.6	-	-	0	0	100%	1
6E7S_NAG_A_507	1%	69%	0.459	0.606	0.32	0.85	-	1	1	0	100%	1
5TQ0_NAG_A_501	70%	87%	0.093	0.908	0.25	0.44	-	-	0	0	100%	1
6E7T_NAG_A_501	64%	76%	0.129	0.927	0.31	0.62	-	-	0	0	100%	1
5EWJ_NAG_A_502	58%	65%	0.181	0.962	0.28	1.05	-	1	0	0	100%	1
6E7W_NAG_C_501	56%	73%	0.12	0.916	0.42	0.63	-	-	10	0	87%	1
6E7X_NAG_A_501	53%	76%	0.184	0.945	0.3	0.63	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.